Reference Hub: FDA warning Lamictal Stevens-Johnson Syndrome

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Featured analysis

A Closer Look at FDA warning Lamictal Stevens-Johnson Syndrome — detailed background and analysis.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

Mayo Clinic — Diseases & Conditions

Reference: Mayo Clinic — Diseases & Conditions

Authoritative source for clinical, regulatory, and public-health background reading.